Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-02 12:46 pm Sale | 13G | PRA Health Sciences Inc. PRAH | MASSACHUSETTS FINANCIAL SERVICES CO | 0 0.000% | -6,116,107 (Position Closed) | View |
| 2021-07-12 4:27 pm Unchanged | 13G | PRA Health Sciences Inc. PRAH | INTEGRATED CORE STRATEGIES (US) LLC | 0 0.000% | 0 (Unchanged) | View |
| 2021-07-12 10:21 am Sale | 13G | PRA Health Sciences Inc. PRAH | VANGUARD GROUP INC | 1,775,342 2.740% | -4,933,799 (-73.54%) | View |
| 2021-04-12 2:07 pm Sale | 13G | PRA Health Sciences Inc. PRAH | PRICE T ROWE ASSOCIATES INC | 3,533,621 5.400% | -3,521,239 (-49.91%) | View |
| 2021-02-16 3:58 pm Purchase | 13G | PRA Health Sciences Inc. PRAH | Capital Research Global Investors | 3,450,676 5.400% | 874,690 (+33.96%) | View |
| 2021-02-16 12:23 pm Purchase | 13G | PRA Health Sciences Inc. PRAH | PRICE T ROWE ASSOCIATES INC | 7,054,860 10.900% | 159,175 (+2.31%) | View |
| 2021-02-11 3:13 pm Purchase | 13G | PRA Health Sciences Inc. PRAH | MASSACHUSETTS FINANCIAL SERVICES CO | 6,116,107 9.500% | 6,116,107 (New Position) | View |
| 2021-02-10 11:40 am Sale | 13G | PRA Health Sciences Inc. PRAH | VANGUARD GROUP INC | 6,709,141 10.460% | -149,074 (-2.17%) | View |
| 2021-02-04 09:57 am Sale | 13G | PRA Health Sciences Inc. PRAH | WELLINGTON MANAGEMENT GROUP LLP | 5,335,089 8.320% | -226,256 (-4.07%) | View |
| 2021-01-26 6:52 pm Sale | 13G | PRA Health Sciences Inc. PRAH | BlackRock Inc. BLK | 6,424,367 10.000% | -22,683 (-0.35%) | View |
| 2020-02-14 1:30 pm Purchase | 13G | PRA Health Sciences Inc. PRAH | PRICE T ROWE ASSOCIATES INC | 6,895,685 10.900% | 525,629 (+8.25%) | View |
| 2020-02-14 12:03 pm Sale | 13G | PRA Health Sciences Inc. PRAH | Capital Research Global Investors | 2,575,986 4.000% | -1,173,258 (-31.29%) | View |
| 2020-02-14 06:41 am Sale | 13G | PRA Health Sciences Inc. PRAH | KKR North America Fund XI L.P. | 0 0.000% | -6,695,984 (Position Closed) | View |
| 2020-02-11 7:19 pm Purchase | 13G | PRA Health Sciences Inc. PRAH | VANGUARD GROUP INC | 6,858,215 10.840% | 25,752 (+0.38%) | View |
| 2020-02-04 12:31 pm Purchase | 13G | PRA Health Sciences Inc. PRAH | BlackRock Inc. BLK | 6,447,050 10.200% | 29,978 (+0.47%) | View |
| 2020-01-28 09:31 am Purchase | 13G | PRA Health Sciences Inc. PRAH | WELLINGTON MANAGEMENT GROUP LLP | 5,561,345 8.790% | 5,561,345 (New Position) | View |
| 2019-12-10 1:26 pm Purchase | 13G | PRA Health Sciences Inc. PRAH | BlackRock Inc. BLK | 6,417,072 10.100% | 258,205 (+4.19%) | View |